Stroke Management Market Poised to Surge from $36.94 Billion to $39.98 Billion in 2024

Dublin, Jan. 28, 2024 (GLOBE NEWSWIRE) -- The "Stroke Management Global Market Report 2024" report has been added to's offering.

The global landscape of stroke management continues its upward trajectory, solidifying its essential role in healthcare services. A recent market research publication added to our comprehensive reports collection indicates a robust compound annual growth rate (CAGR) of 8.2% for the stroke management market, propelling it from its current valuation of $36.94 billion in 2023 to an impressive $39.98 billion in 2024.

This growth echoes the innovative strides within the sector, such as advancements in thrombolytic therapies, preventive initiatives, state-of-the-art rehabilitation techniques, as well as the continued integration of telemedicine in stroke care—all of which are catalyzing the expansion of collaborative stroke networks worldwide.

Looking ahead, the stroke management market is forecasted to reach a staggering $52.89 billion by 2028, with a steady CAGR of 7.2%. This forecasted growth is attributed to the advent of powerful neuroprotective therapies, the deployment of artificial intelligence for stroke diagnosis, and the individualization provided through personalized medicine. Global stroke care is set to thrive on the back of enhanced acute care access and efforts to standardize stroke treatment protocols internationally.

Industry Growth Drivers

  • The prevalence of chronic diseases, requiring continuous management and care, serves as a primary catalyst, reinforcing the market's upward momentum.

  • An upsurge in the aging population globally necessitates escalated demand for comprehensive stroke management.

Technological Innovations Spur Market Evolution

The implementation of trailblazing technologies stands out as a trend with significant traction, bolstering advancements in stroke management capabilities. Innovators are leveraging cutting-edge solutions to heighten diagnostics precision and treatment efficacy, reshaping the industry landscape. An exemplar is the advent of AI platforms capable of expediting emergency stroke case assessments, underpinning notable companies' commitment to pushing the envelope in medical interventions.

A selection of companies mentioned in this report includes

  • GE HealthCare Technologies Inc.
  • Abbott Laboratories
  • Medtronic plc
  • Boston Scientific Corporation
  • B Braun Melsungen AG
  • Bristol Myers Squibb Co.
  • Cardinal Health Inc.
  • Glaxosmithkline Plc
  • Siemens AG
  • Merck And Co. Inc.
  • Asahi Intech Co. Ltd.
  • Johnson & Johnson
  • Penumbra Inc.
  • Teleflex Inc.
  • Stryker Corporation
  • Biogen Inc.
  • Bayer AG
  • Philips Healthcare
  • AstraZeneca Plc.
  • F. Hoffmann-la Roche
  • Novartis AG
  • Takeda Pharmaceutical Company Ltd.
  • Sanofi SA
  • Daiichi Sankyo Company Limited
  • Boehringer Ingelheim International GmbH
  • Pfizer Inc.
  • Integer Holdings Corporation

For more information about this report visit

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.


Contact Data